DE69934242D1 - Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen - Google Patents

Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen

Info

Publication number
DE69934242D1
DE69934242D1 DE69934242T DE69934242T DE69934242D1 DE 69934242 D1 DE69934242 D1 DE 69934242D1 DE 69934242 T DE69934242 T DE 69934242T DE 69934242 T DE69934242 T DE 69934242T DE 69934242 D1 DE69934242 D1 DE 69934242D1
Authority
DE
Germany
Prior art keywords
polycetide
preparation
recombinant dna
dna constructs
synthase enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69934242T
Other languages
English (en)
Other versions
DE69934242T2 (de
Inventor
Christopher Reeves
Daniel Chu
Chaitan Khosla
Daniel Santi
Kai Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kosan Biosciences Inc
Original Assignee
Kosan Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kosan Biosciences Inc filed Critical Kosan Biosciences Inc
Publication of DE69934242D1 publication Critical patent/DE69934242D1/de
Application granted granted Critical
Publication of DE69934242T2 publication Critical patent/DE69934242T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/32—Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DE69934242T 1998-10-02 1999-10-01 Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen Expired - Fee Related DE69934242T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US10274898P 1998-10-02 1998-10-02
US102748P 1998-10-02
US12381099P 1999-03-11 1999-03-11
US123810P 1999-03-11
US13965099P 1999-06-17 1999-06-17
US139650P 1999-06-17
PCT/US1999/022886 WO2000020601A2 (en) 1998-10-02 1999-10-01 Polyketide synthase enzymes and recombinant dna constructs therefor

Publications (2)

Publication Number Publication Date
DE69934242D1 true DE69934242D1 (de) 2007-01-11
DE69934242T2 DE69934242T2 (de) 2007-09-20

Family

ID=27379409

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934242T Expired - Fee Related DE69934242T2 (de) 1998-10-02 1999-10-01 Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen

Country Status (13)

Country Link
US (5) US6503737B1 (de)
EP (1) EP1117801B1 (de)
JP (1) JP2002526114A (de)
KR (1) KR20010085877A (de)
CN (1) CN1329668A (de)
AT (1) ATE346938T1 (de)
AU (2) AU773517B2 (de)
CA (1) CA2343880C (de)
DE (1) DE69934242T2 (de)
IL (1) IL142165A0 (de)
MX (1) MXPA01003376A (de)
NZ (1) NZ510819A (de)
WO (1) WO2000020601A2 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4579351B2 (ja) 1996-12-03 2010-11-10 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ エポチロンの合成とその中間体及びその類似物並びにその使用
US6204388B1 (en) * 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
ATE346938T1 (de) * 1998-10-02 2006-12-15 Kosan Biosciences Inc Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
US6569867B2 (en) 1999-10-01 2003-05-27 Kosan Biosciences, Inc. Polyketide derivatives
JP5142435B2 (ja) * 1999-10-13 2013-02-13 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ ポリケチド合成基質の生合成
US6939691B1 (en) 1999-10-13 2005-09-06 Board Of Trustees Of The Leland Stanford Junior University E. coli and Streptomyces host cells that contain MatBC genes or E. coli host cells that contain pcc genes useful for enhanced polyketide production
US6627427B1 (en) * 1999-10-25 2003-09-30 Kosan Biosciences, Inc. Heterologous production of 15-methyl-6-deoxyerthronolide B
AU1105201A (en) * 1999-10-27 2001-05-08 Kosan Biosciences, Inc. Heterologous production of polyketides
ATE356880T1 (de) 1999-10-29 2007-04-15 Kosan Biosciences Inc Rapamycin analoge
US6562795B2 (en) 2000-02-18 2003-05-13 Kosan Biosciences, Inc. Motilide compounds
CA2407259A1 (en) * 2000-05-17 2001-11-22 Chaitan Khosla Polyketide derivatives
US20030050692A1 (en) * 2000-12-22 2003-03-13 Avantec Vascular Corporation Delivery of therapeutic capable agents
JP2005506044A (ja) * 2001-02-28 2005-03-03 ザ、ボード、オブ、トラスティーズ、オブ、ザ、リーランド、スタンフォード、ジュニア、ユニバーシティ ポリケチドシンターゼ基質の生合成
FR2825717B1 (fr) 2001-06-08 2005-02-18 Rhodia Chimie Sa Preparation stereoselective de l-acides amines cycliques
US7452692B2 (en) * 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
US7432074B2 (en) * 2002-02-13 2008-10-07 TEVA Gyógyszergyár Zártkörüen MüködöRészvénytársaság Method for extracting a macrolide from biomatter
JP4765032B2 (ja) 2002-02-19 2011-09-07 ダウ・アグロサイエンス・エル・エル・シー 新規スピノシンを産生するポリケチド合成酵素
US7195907B2 (en) 2002-03-29 2007-03-27 Wyeth Non-ribosomal peptide synthetases and associated biosynthetic genes
WO2003082909A1 (en) * 2002-03-29 2003-10-09 Wyeth Non-ribosomal peptide synthetases and associated biosynthetic genes
DE60315723T2 (de) * 2002-07-16 2008-06-19 Biotica Technology Ltd. Herstellung von Polyketiden und anderen natürlichen Produkten
AU2007237187B2 (en) * 2002-07-16 2010-08-05 Biotica Technology Limited Production of polyketides
DK1767535T3 (da) * 2002-08-23 2010-04-12 Sloan Kettering Inst Cancer Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US7799904B2 (en) * 2003-06-13 2010-09-21 University Of Kentucky Research Foundation Gilvocarcin gene cluster, recombinant production and use thereof
KR20060110865A (ko) * 2003-11-27 2006-10-25 에자이 가부시키가이샤 매크로라이드계 화합물의 수산화에 관여하는 ｄｎａ
FR2869044B1 (fr) * 2004-04-16 2006-07-14 Korea Advanced Inst Sci & Tech Genes pour la synthese de polyketides fr-008
EP1751279A4 (de) * 2004-05-05 2008-03-19 Univ Minnesota An der herstellung von cryptophycin beteiligte nukleinsäuren und polypeptide
WO2005109236A2 (en) * 2004-05-06 2005-11-17 Acco Brands, Inc. Apparatus and method for determining an optimal ergonomic setup
AU2005252673A1 (en) * 2004-06-03 2005-12-22 Wyeth Biosynthetic gene cluster for the production of a complex polyketide
KR100834488B1 (ko) * 2004-07-20 2008-06-09 에자이 알앤드디 매니지먼트 가부시키가이샤 플라디에놀라이드의 생합성에 관여하는 폴리펩티드를코딩하는 ｄｎａ
WO2006069333A1 (en) * 2004-12-22 2006-06-29 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Method of purifying macrolides
WO2006083486A1 (en) * 2005-01-05 2006-08-10 TEVA GYÓGYSZERGYÁR ZÁRTKöR..EN M..k..D.. RÉSZVÉNYTÁRSASÁG Amorphous tacrolimus and preparation thereof
TW200716744A (en) * 2005-05-26 2007-05-01 Eisai R&D Man Co Ltd Genetically modified microorganism and process for production of macrolide compound using the microorganism
DE602007006601D1 (de) * 2006-03-15 2010-07-01 Teva Gyogyszergyar Zartkoeruee Verfahren zur reinigung von tacrolimus
US7566558B2 (en) * 2006-07-28 2009-07-28 Regents Of The University Of Michigan Nucleic acids and polypeptides involved in the production of cryptophycin
US8759031B2 (en) * 2007-04-12 2014-06-24 Wisconsin Alumni Research Foundation Type I polyketide synthase extender units
EP2272963A1 (de) 2009-07-09 2011-01-12 LEK Pharmaceuticals d.d. Verfahren zur Herstellung von Tacrolimus
KR101189475B1 (ko) * 2009-12-03 2012-10-15 (주) 제노텍 삼원환 화합물의 생합성을 담당하는 유전자와 단백질
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
MX2013008062A (es) 2011-01-28 2013-08-09 Amyris Inc Seleccion de microcolonias encapsuladas en gel.
WO2012158466A1 (en) 2011-05-13 2012-11-22 Amyris, Inc. Methods and compositions for detecting microbial production of water-immiscible compounds
MX356894B (es) 2011-09-19 2018-06-19 Dow Global Technologies Llc Estructuras por capas y artículos a partir de las mismas.
US10927382B2 (en) 2012-08-07 2021-02-23 Amyris, Inc. Methods for stabilizing production of acetyl-coenzyme a derived compounds
US9121859B2 (en) * 2012-12-04 2015-09-01 Siemens Healthcare Diagnostics Inc. Compounds and methods for determination of FKBP-binding immunosuppressant drugs
US9410214B2 (en) 2013-03-15 2016-08-09 Amyris, Inc. Use of phosphoketolase and phosphotransacetylase for production of acetyl-coenzyme A derived compounds
WO2015020649A1 (en) 2013-08-07 2015-02-12 Amyris, Inc. Methods for stabilizing production of acetyl-coenzyme a derived compounds
US10533016B2 (en) 2015-01-09 2020-01-14 Revolution Medicines, Inc. Compounds that participate in cooperative binding and uses thereof
BR112017027869A2 (pt) 2015-06-25 2018-09-11 Amyris, Inc. degrons dependentes de maltose, promotores responsivos à maltose, construtos de estabilização, e seu uso na produção de compostos não catabólicos
US9989535B2 (en) 2015-10-01 2018-06-05 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
KR102615448B1 (ko) 2016-04-12 2023-12-19 징코 바이오웍스, 인크. 화합물의 제조를 위한 조성물 및 방법
EP3532633A4 (de) 2016-10-28 2020-09-09 Ginkgo Bioworks Inc. Zusammensetzungen und verfahren zur herstellung von verbindungen
WO2018081590A1 (en) * 2016-10-28 2018-05-03 Warp Drive Bio, Inc. Compositions and methods for the production of compounds
KR102109168B1 (ko) * 2018-12-11 2020-05-12 인트론바이오테크놀로지 신규 화합물 및 이를 포함하는 진균감염 치료용 약학적 조성물
CN109943545B (zh) * 2019-03-29 2021-08-03 浙江大学 一种酰基转移酶结构域定向改造合成化合物的方法
US11827837B2 (en) * 2019-04-02 2023-11-28 King Fahd University Of Petroleum And Minerals Water-based drilling, completion, and workover fluid composition with reduced barite sagging
KR20220109408A (ko) 2019-11-04 2022-08-04 레볼루션 메디슨즈, 인크. Ras 억제제
CN115873020A (zh) 2019-11-04 2023-03-31 锐新医药公司 Ras抑制剂
EP4055028A1 (de) 2019-11-04 2022-09-14 Revolution Medicines, Inc. Ras-inhibitoren
TW202227460A (zh) 2020-09-15 2022-07-16 美商銳新醫藥公司 Ｒａｓ抑制劑

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5149639A (en) 1986-03-24 1992-09-22 Abbott Laboratories Biologically pure cultures of streptomyces and use thereof in macrolide antibiotic production
US4874748A (en) 1986-03-24 1989-10-17 Abbott Laboratories Cloning vectors for streptomyces and use thereof in macrolide antibiotic production
EP0346427B1 (de) 1987-12-09 1995-03-29 FISONS plc Makrozyklische verbindungen
US5063155A (en) 1988-03-28 1991-11-05 Eli Lilly And Company Method for producing 2"'-o-demethyltylosin
US5098837A (en) 1988-06-07 1992-03-24 Eli Lilly And Company Macrolide biosynthetic genes for use in streptomyces and other organisms
EP0356399A3 (de) 1988-08-26 1991-03-20 Sandoz Ag Substituierte 4-Azatricyclo (22.3.1.04.9) octacos-18-en-Derivate, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen
CA2044846A1 (en) 1990-06-25 1991-12-26 Thomas R. Beattie Antagonists of immunosuppressive macrolides
US5824513A (en) 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
WO1993013663A1 (en) 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US5189042A (en) 1991-08-22 1993-02-23 Merck & Co. Inc. Fluoromacrolides having immunosuppressive activity
ES2164713T3 (es) 1993-09-20 2002-03-01 Univ Leland Stanford Junior Produccion recombinante de nuevos poliquetidos.
US5712146A (en) 1993-09-20 1998-01-27 The Leland Stanford Junior University Recombinant combinatorial genetic library for the production of novel polyketides
US5672491A (en) 1993-09-20 1997-09-30 The Leland Stanford Junior University Recombinant production of novel polyketides
NZ313383A (en) 1995-07-06 1999-08-30 Univ Leland Stanford Junior Cell-free synthesis of polyketides using pks (polyketide synthase)
US6033883A (en) 1996-12-18 2000-03-07 Kosan Biosciences, Inc. Production of polyketides in bacteria and yeast
CA2288030A1 (en) 1997-04-30 1998-11-05 Kosan Biosciences, Inc. Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold
US5968921A (en) 1997-10-24 1999-10-19 Orgegon Health Sciences University Compositions and methods for promoting nerve regeneration
FR2780774B1 (fr) * 1998-07-03 2001-03-09 Alkan Sa Dispositif d'autoprotection passive pour engin mobile tel qu'un helicoptere
US6150513A (en) 1998-09-16 2000-11-21 Kosan Biosciences, Inc. Polyketide synthase enzymes and recombinant DNA constructs therefor
ATE346938T1 (de) * 1998-10-02 2006-12-15 Kosan Biosciences Inc Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen

Also Published As

Publication number Publication date
EP1117801B1 (de) 2006-11-29
CA2343880C (en) 2008-08-26
KR20010085877A (ko) 2001-09-07
ATE346938T1 (de) 2006-12-15
USRE39762E1 (en) 2007-08-07
WO2000020601A9 (en) 2000-08-31
MXPA01003376A (es) 2002-11-07
AU2004202308A1 (en) 2004-06-24
CN1329668A (zh) 2002-01-02
AU773517B2 (en) 2004-05-27
US20020010328A1 (en) 2002-01-24
CA2343880A1 (en) 2000-04-13
NZ510819A (en) 2004-03-26
IL142165A0 (en) 2002-03-10
US6660862B2 (en) 2003-12-09
WO2000020601A2 (en) 2000-04-13
US6503737B1 (en) 2003-01-07
WO2000020601A3 (en) 2000-10-26
AU1441500A (en) 2000-04-26
JP2002526114A (ja) 2002-08-20
US20090186378A1 (en) 2009-07-23
US6759536B2 (en) 2004-07-06
EP1117801A2 (de) 2001-07-25
DE69934242T2 (de) 2007-09-20
US20030175901A1 (en) 2003-09-18
US7714118B2 (en) 2010-05-11

Similar Documents

Publication Publication Date Title
DE69934242D1 (de) Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
WO1999057325A3 (en) Enzymes mixture
AU2002235994A1 (en) Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same
ATE360706T1 (de) Peptidakzeptor ligationsverfahren
DK1117672T3 (da) Antisense-modulation af survivin-ekpression
WO2002038806A3 (de) Nachweis von nukleinsäure-polymorphismen
EA200400186A1 (ru) Регуляция экспрессии хинолятфосфорибозил-трансферазы
EA200100589A1 (ru) Азабициклоалканы как модуляторы ccr5
WO1999054459A8 (en) Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
IL143670A0 (en) Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same
DE60127441D1 (de) Dipeptidylpeptidasen
WO2003012057A3 (en) Antisense modulation of serum amyloid a4 expression
EP2199299A3 (de) Antisens-Modulation der Expression von Survivin
DE60313659D1 (de) Borrelidin-derivate und ihre medizinische anwendung
DE60114865D1 (de) Heterologe herstellung von polyketiden
DK1206484T3 (da) Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese
WO2003022222A3 (en) Antisense modulation of protein kinase r expression
EP1135402A4 (de) Antisense modulation der egr-1 expression
DE60036159D1 (de) Für flavonsynthase kodierendes gen
EP1224202A4 (de) Antisense modulierung der integrin-mediierten kinase expression
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
WO2001029175A3 (en) Antisense modulation of fra-1 expression
WO2002062818A3 (en) Antisense modulation of casein kinase 2-alpha expression
AR027256A1 (es) Deteccion de microorganismos relacionados con la fermentacion
WO2001079167A3 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee